Entrada Skyrockets On $250 Million Deal With Vertex In Muscular DystrophyInvestors Business Daily • 12/08/22
Vertex and Entrada Therapeutics Establish Collaboration to Discover and Develop Endosomal Escape Vehicle (EEV) Therapeutics for Myotonic Dystrophy Type 1 (DM1)Business Wire • 12/08/22
BioNTech, Vertex Pharmaceuticals And Other Big Biotechnology Stocks From Benzinga's Most Accurate Analysts - Beam Therapeutics (NASDAQ:BEAM), BioNTech (NASDAQ:BNTX)Benzinga • 12/02/22
Vertex Pharmaceuticals Incorporated present at 5th Annual Evercore ISI HealthCONx Conference (Transcript)Seeking Alpha • 12/01/22
Looking for a Once-in-a-Decade Buying Opportunity? Buy These 3 Stocks Before 2023The Motley Fool • 12/01/22
Vertex Pharmaceuticals: Growth Outside Of Cystic Fibrosis Critical For Additional Value CreationSeeking Alpha • 11/29/22
Why Vertex Pharmaceuticals (VRTX) is a Top Value Stock for the Long-TermZacks Investment Research • 11/21/22
Vertex Pharmaceuticals Incorporated (VRTX) Jefferies London Healthcare Conference (Transcript)Seeking Alpha • 11/16/22